Skip to content

Role of Femoral Nerve Block on Prevention of Postoperative Deep Venous Thromboembolism

Prevention of Deep Venous Thromboembolism: Effect of Preemptive Analgesic of Femoral Nerve Block in Patients Undergoing Total Knee Arthroplasty

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02411097
Enrollment
120
Registered
2015-04-08
Start date
2014-09-30
Completion date
2015-10-31
Last updated
2015-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gonarthrosis

Keywords

Deep venous thromboembolism, Femoral nerve block, Total knee arthroplasty

Brief summary

To investigate whether preemptive analgesic of femoral nerve block could prevent deep venous thromboembolism due to inhibiting the excessive release of neutrophil elastase and inflammatory cytokines.

Detailed description

Femoral nerve block is an effective analgesic mode in patients after total knee arthroplasty. In recent studies, there has been shown that a large amount of neutrophil elastase release from neutrophils could induce the development of deep venous thromboembolism and femoral nerve block may reduce the incidence of the development of deep venous thromboembolism. In addition, inflammatory cytokines including interleukin-1(IL-1), IL-6, IL-8 and tumor necrosis factor(TNF) were associated with deep venous thromboembolism. Thus, the investigators hypothesised that preemptive analgesic of femoral nerve block could prevent deep venous thromboembolism due to inhibiting the excessive release of neutrophil elastase and inflammatory cytokines.

Interventions

PROCEDUREfemoral nerve block

use the nerve stimulator,the femoral nerve block will be administered before or after the surgery

Sponsors

General Hospital of Ningxia Medical University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* adult patients scheduled for total knee arthroplasty under general anesthesia

Exclusion criteria

* ASA physical status Ⅳ-Ⅴ, * psychiatric illness, * chronic opioid consumption, * patient refusal, * coagulopathy, * peripheral neurological injury, * local anesthesia drug allergy, * preoperative existing deep venous thromboembolism.

Design outcomes

Primary

MeasureTime frame
Serum concentration of inflammatory cytokinechange from baseline at 30min, 60min, 90min after using tourniquet and 12h, 24h,48h after operation

Secondary

MeasureTime frameDescription
Concentration of related inflammatory factors of deep venous thromboembolismchange from baseline at 30min, 60min, 90min after using tourniquet and 12h, 24h,48h after operationinflammatory factors include IL-1, IL-6, IL-8 and TNF,detecting the concentrations by enzyme-linked immunosorbent assay (ELISA).

Other

MeasureTime frameDescription
Diagnosis of deep venous thromboembolism by ultrasonography2day and 7day after operationresult of diagnosis is yes or no

Countries

China

Contacts

Primary ContactXinli Ni
xinlini6@yahoo.com+086 951-6743252

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026